About Suanfarma
Suanfarma is a Healthcare company based in Madrid (Spain) founded in 1993, and was acquired by ARCHIMED in November 2021. Generics, nutraceuticals, and APIs are developed by Suanfarma. The company has 7 employees. Suanfarma has completed 3 acquisitions, including Cidqo, Cipan and Monteloeder. Its Indian entity Indisuan Pharmaceuticals Private Limited reported revenue of βΉ31.12 Cr. Suanfarma offers products and services including Active Pharmaceutical Ingredients, CDMO Services, and Intermediate Products. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.
Company details
Suanfarma was founded in 1993 in Madrid, Spain. The company is focused on the pharmaceutical sector, where generics, nutraceuticals, and active pharmaceutical ingredients are developed. Operations encompass research, formulation, and supply chain management for these products. Services are extended to international clients, with primary activities based in Europe. Expansion into global markets has been pursued through partnerships and regulatory compliance.
- Headquarters Madrid, Spain
- Employees 7
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website suanfarma.com
- Social LinkedIn X YouTube
- Acquired by ARCHIMED (Nov 2021)
- Legal Name Indisuan Pharmaceuticals Private Limited
- Date of Incorporation 28 Mar, 2018
- Jurisdiction Navi Mumbai, Maharashtra, India
Associated legal entities of Suanfarma
Suanfarma operates through Indisuan Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indisuan Pharmaceuticals Private Limited CIN U51909MH2018FTC307297 | Active | 28 Mar 2018 | Navi Mumbai, Maharashtra | ₹31.1 Cr | 7 | 2 | View details |
Products & Services of Suanfarma
Suanfarma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, CDMO Services, and Intermediate Products.
High-quality ingredients for human and veterinary drug manufacturing.
Integrated end-to-end solutions for pharmaceutical development and production.
Raw materials used in pharmaceutical ingredient synthesis.
Apps and channels of Suanfarma
its YouTube channel Suanfarma has 51 subscribers and 7 videos.
Videos from Suanfarma
The most watched videos on Suanfarma's YouTube channel, Suanfarma (51 subscribers). Click a video to play it here.
More on Suanfarma.
Investors in Suanfarma
Suanfarma has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include ICG, ProA Capital and ARCHIMED.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| proacapital.com | ||||
ICG is recognized as a global alternative asset manager. | 1989 | icgam.com | London, United Kingdom | |
Healthcare industries are funded and supported globally by ARCHIMED. | archimed.group | Lyon, France |
Investor details for Suanfarma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Indisuan Pharmaceuticals Private Limited (Suanfarma)
Indisuan Pharmaceuticals Private Limited is the primary company behind Suanfarma. The board of Indisuan Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Jawed Zia, appointed in 2025. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jawed Zia DIN 00191276 | Additional Director | 31 Jan 2025 | 1 yr 9 mo | Indisuan Pharmaceuticals Private Limited |
| Amol Pramod Salvi DIN 11044007 | Additional Director | 07 Apr 2025 | 1 yr 7 mo | Indisuan Pharmaceuticals Private Limited |
Financials of Suanfarma
Figures of Indisuan Pharmaceuticals Private Limited, the primary company behind Suanfarma, for FY 2025. Revenue was ₹31.12 Cr (-55% year on year). Net profit was ₹66.1 Lakh (2% margin). EBITDA was ₹2.34 Cr (8% margin). Revenue has grown at a compounded annual rate of -13% over three years and -3% over five years.
- ₹31.12 CrRevenue · FY 2025 · -55% YoY
- ₹66.1 LakhNet profit · 2% margin
- ₹2.34 CrEBITDA · 8% margin
- ₹10 LakhPaid-up capital
- 7Employees (provident fund records)
- -13%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indisuan Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Suanfarma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Suanfarma
Suanfarma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cidqo, Cipan and Monteloeder.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Nutraceutical ingredients are supplied for supplements, cosmetics, and nutrition. | monteloeder.com | Elche, Spain | 1996 | Feb 2022 | β’β’β’β’ | |
Antibiotic-based Active Pharmaceutical Ingredients and Intermediates are developed and manufactured. | cipan.pt | Castanheira Do Ribatejo, Portugal | 1960 | Sep 2016 | β’β’β’β’ | |
Pharmaceuticals and intermediates are developed using combinatorial chemistry. | cidqo.com | Barcelona, Spain | 2012 | Mar 2013 | β’β’β’β’ |
Complete acquisition details for Suanfarma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Suanfarma
7 dated milestones of Suanfarma across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Suanfarma is founded.
- Acquisition Acquires Cidqo.
- Exit Acquired by ProA Capital.
- Acquisition Acquires Cipan.
- Exit Acquired by ICG.
- Exit Acquired by ARCHIMED.
- Acquisition Acquires Monteloeder.
Web traffic of Suanfarma
The website of Suanfarma (suanfarma.com) receives about 7.4K visits a month and ranks #3,394,565 among all websites worldwide, #4,442 in Biotechnology and Pharmaceuticals.
- Monthly visits7.4K
▲ 40.9% vs previous month
- Unique visitors2.2K
per month
- Global rank#3,394,565
among all websites
- Category rank#4,442
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit2.1
- Average visit54 sec
- DevicesDesktop 39% Β· Mobile 61%
Websites whose visitors overlap most with Suanfarma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
artsenbezoeker.vacatures-stoevelaar.com | artsenbezoeker.vacatures-stoevelaar.com | 100% | β | ||
completfarma.com | completfarma.com | 62% | β | ||
heberfarma.com | heberfarma.com | 62% | #4,788,925 | β | |
mapbiopharma.es | mapbiopharma.es | 36% | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Suanfarma
Complete news archive for Suanfarma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suanfarma
Suanfarma was founded in 1993.
Suanfarma is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Suanfarma has 7 employees.
The primary company behind Suanfarma, Indisuan Pharmaceuticals Private Limited, reported revenue of βΉ31.12 Cr for FY 2025, down 55% year on year.
Suanfarma was founded in 1993 in Madrid, Spain. The company is focused on the pharmaceutical sector, where generics, nutraceuticals, and active pharmaceutical ingredients are developed. Operations encompass research, formulation, and supply chain management for these products. Services are extended to international clients, with primary activities based in Europe. Expansion into global markets has been pursued through partnerships and regulatory compliance.
Suanfarma offers Active Pharmaceutical Ingredients, CDMO Services, and Intermediate Products.
Suanfarma has made 3 acquisitions, including Cidqo, Cipan, and Monteloeder.
Suanfarma operates through Indisuan Pharmaceuticals Private Limited.
Yes. Suanfarma was acquired by ARCHIMED in November 2021.
The legal entities of Suanfarma currently have 2 directors, including Jawed Zia, Amol Pramod Salvi.

